Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Talesa, Vincenzo N.a; 1 | Antognelli, Cinziaa | Del Buono, Chiaraa | Stracci, Fabriziob | Serva, Maria R.c | Cottini, Emanuelec | Mearini, Ettorec; *
Affiliations: [a] Department of Experimental Medicine, University of Perugia, Perugia, Italy | [b] Department of Medical-Surgical Specialties and Public Health, Public Health Division, University of Perugia, Perugia, Italy | [c] Department of Medical-Surgical Specialties and Public Health, Division of Urology and Andrology, University of Perugia, Perugia, Italy
Correspondence: [*] Corresponding author: Ettore Mearini, Department of Medical-Surgical Specialties and Public Health, Division of Urology and Andrology, University of Perugia, Perugia, Italy. Tel./Fax: +39 075 5724890; E-mail: talesa@unipg.it.
Note: [1] Vincenzo N. Talesa and Cinzia Antognelli contributed equally to this study.
Abstract: Prostate cancer (PCa) is a heterogeneous, multifactorial and multifocal disease. Therefore, the search for a combination of assays using a panel of tumor markers is fundamental for a more precise and reliable diagnosis. In the present study we investigated the diagnostic value of five different genes, associated with PCa carcinogenesis, encoding for prostate-specific membrane antigen (PSMA), serine protease Hepsin, PCa antigen 3 (PCA3), UDP-N-acetyl-α-D-galatosamine transferase (GalNAC-T3) and prostate-specific antigen (PSA). Forty-four patients, with previously untreated, histologically verified PCa and forty-six patients with benign prostatic hyperplasia (BPH) were enrolled in this study. Absolute concentration of the transcript levels of each gene was calculated by quantitative Real-Time PCR analysis in urine sediments of men suffering from PCa or BPH after prostatic massage. The diagnostic value of a concomitant examination of these markers was evaluated by logistic regression analysis. We demonstrated that the diagnostic potential of the combined urinary PSA and PSMA level was significantly better than that of each singularly considered marker, including total serum PSA, the present gold standard test for PCa diagnosis.
Keywords: PCA3/DD3, PSMA, PSA, panel of urinary biomarkers, prostate cancer
DOI: 10.3233/CBM-2009-0109
Journal: Cancer Biomarkers, vol. 5, no. 6, pp. 241-251, 2009
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl